Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Maker of Ingredient for Fen-Phen Not Liable
The maker of a component ingredient of the diet drug Fen-Phen cannot be sued over the drug, a Philadelphia Common Pleas Court judge has ruled, because the trial court found that the defendant in the mass tort litigation that resulted in a $4 billion settlement was solely responsible. Sokoloski v. American Home Products Corp., PICS NO. 03-0073. In addition, as the producer of only a component ingredient of Fen-Phen, Les Servier owed no duty to the plaintiffs.
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
This article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.
When we consider how the use of AI affects legal PR and communications, we have to look at it as an industrywide global phenomenon. A recent online conference provided an overview of the latest AI trends in public relations, and specifically, the impact of AI on communications. Here are some of the key points and takeaways from several of the speakers, who provided current best practices, tips, concerns and case studies.
The parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.